Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings ...
Nigeria has raised serious concern over the growing number of HIV infections among young women worldwide, revealing that about 4,000 girls aged 15 to 24 contract HIV every week.This was disclosed in a ...
When I got into that preschool classroom, I forgot about my HIV diagnoses...I couldn’t have time to be helpless.' Gwendolyn Sullivan said.
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that it will deliver data from six presentations at IDWeek 2025, including clinical data, ...
The PLHIVs under National Empowerment Network of People Living with HIV/AIDS in Kenya (NEPHAK) also want clarity on user fees ...